A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout (Q46479794)
Jump to navigation
Jump to search
scientific article published on 16 July 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout |
scientific article published on 16 July 2008 |
Statements
1 reference
A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout (English)
1 reference
M K Reinders
1 reference
C Haagsma
1 reference
T L Th A Jansen
1 reference
E N van Roon
1 reference
J Delsing
1 reference
M A F J van de Laar
1 reference
J R B J Brouwers
1 reference
16 July 2008
1 reference
1 reference
68
1 reference
892-897
1 reference
6
1 reference
Identifiers
1 reference
1 reference